Everest Medicines' Zetomipzomib IND Accepted in China

-- Everest plans to contribute to the ongoing global Phase 2b PALIZADE trial of zetomipzomib in active lupus nephritis –  -...

December 04, 2023 | Monday | News
Pfizer Reveals Positive Phase 2b Results for Obesity Drug Danuglipron

Danuglipron demonstrated mean placebo-adjusted weight reductions ranging from -8% to -13% at 32 weeks and -5% to -9.5% at 26 weeks While most common adv...

December 04, 2023 | Monday | News
ShiraTronics Launches First-Ever Trial for Chronic Migraine Therapy in Australia.

This development underscores the company's commitment to advancing innovative solutions that provide relief and improved quality of life for the millions o...

November 30, 2023 | Thursday | News
Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million Biologics Test...

November 29, 2023 | Wednesday | News
Skye Bioscience Initiates Phase 2 Study for Glaucoma Treatment SBI-100

SBI-100 Ophthalmic Emulsion, a CB1 agonist/activator delivered as a topical eye drop, was developed to treat patients with elevated intraocular pressure ...

November 28, 2023 | Tuesday | News
Immutep Expands INSIGHT-003 Phase I Trial Site in Australia

This site expansion will support faster enrolment in this cost-efficient, investigator-initiated study evaluating eftilagimod alpha (efti) in combination w...

November 24, 2023 | Friday | News
Junshi Biosciences' VV116 COVID-19 Treatment Hits Lancet Infectious Diseases in Phase 3 Study Results

The paper presents final analysis results from a multicenter, double-blind, phase 3, randomized controlled study (NCT05582629) evaluating the efficacy and ...

November 24, 2023 | Friday | News
CG Pharmaceuticals Initiates Phase 2 Study for Metastatic Pancreatic Cancer

The RP2D of ivaltinostat (250 mg/m2) was determined by the Safety Review Committee (SRC) following a thorough safety data review from 3 cohorts of increasi...

November 20, 2023 | Monday | News
Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer

"The NMPA approval of vebreltinib is an important milestone toward providing a new treatment option for patients with MET exon 14 skipping NSCLC in China. ...

November 17, 2023 | Friday | News
SciSparc Celebrates Major Breakthrough with Positive Results Demonstrating Remarkable Impact on Alzheimer's Agitation in Treatment

SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central...

November 16, 2023 | Thursday | News
Global Coalition and Cure Brain Cancer Foundation Open Glioblastoma Trial in Australia

GBM AGILE Adaptive Platform Trial Recruiting in Australia Austin Health in Melbourne and Royal North Shore Hospital in Sydney are Now Enrolling Patients ...

November 15, 2023 | Wednesday | News
FDA Clears Solid Biosciences' Gene Therapy for Duchenne Muscular Dystrophy

Planning to initiate Phase 1/2 trial in pediatric DMD Patients – – First cohort to study patients 4 to < 6 years of age –   &l...

November 15, 2023 | Wednesday | News
Hepion Pharmaceuticals Reports Significant Liver Stiffness Reduction in Advanced MASH Liver Disease Study

Demonstrated improvements among best reported of fibrosis-reducing compounds - - Liver stiffness results complemented by positive changes in disease bioma...

November 14, 2023 | Tuesday | News
Bio-Botanica®'s Puresterol® Serums Show Wrinkle Reduction in Clinical Trials

Pueraria mirifica grows only in the rich soils of the high-altitude rainforests of Thailand and has been used by the Thais for a millennium as a rejuvenato...

November 10, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in